VP, Generative AI for Biotherapeutics & Antibody Design

100 Eli Lilly and Company; San Diego (CA); On-site; USD 267,000 - 392,000; Full time

Benefits offered by this job

401(k) matching

Pension

Vacation benefits

Medical, dental, vision benefits

Job summary

Lilly seeks an AVP of Generative Foundation Models for Biotherapeutics to shape the scientific strategy for protein foundation models, starting with antibodies and VHHs. You will build a world-class AI research team and translate innovations into Lilly’s discovery portfolio, advancing de novo biologics design.

You will define training strategies, scale models, and collaborate with antibody engineers and biologists to drive impact, while attracting top talent and leading a strategic,

Qualifications

• Ph.D. in computer science, mathematics, physics, computational biology, or a related quantitative STEM field with 5+ years post-Ph.D. research (or M.S. with 10+ years) including 3+ years as a supervisor.
• Track record in generative or predictive modeling for protein structure, sequence design, or molecular interaction, with first-author contributions.
• Experience training deep learning models at scale on multi-node GPU infrastructure; fluent in Python and PyTorch.

Responsibilities

• Define and execute a scientific strategy for protein foundation models.
• Lead the team to establish structure-based generative models for de novo antibody design.
• Build and lead a world-class AI research organization at LillyBioTDR in San Diego.

Skills

Generative modeling

Deep learning at scale

Python

PyTorch

Leadership & supervision

Education

Ph.D. in computer science, mathematics, physics, computational biology, or related STEM

M.S. with 10+ years post-Ph.D. experience

Tools

PyTorch

Multi-node GPU infrastructure

Job description

Lilly seeks an AVP of Generative Foundation Models for Biotherapeutics to shape the scientific strategy for protein foundation models, starting with antibodies and VHHs. You will build a world-class AI research team and translate innovations into Lilly’s discovery portfolio, advancing de novo biologics design.

You will define training strategies, scale models, and collaborate with antibody engineers and biologists to drive impact, while attracting top talent and leading a strategic,